Cardiac Myosin Activator Shows Promise for LV Function 'More hands pulling on the rope'
ORLANDO -- A selective cardiac myosin activator showed potential ties to improved left ventricular (LV) function and symptoms in some heart failure patients with reduced ejection fraction, according to two analyses of the COSMIC-HF study.